<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab3" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <p>The pharmacological effects of FCB.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">Pharmacological effects</th>
    <th align="center" rowspan="1" colspan="1">Extract/compounds</th>
    <th align="center" rowspan="1" colspan="1">Study models</th>
    <th align="center" rowspan="1" colspan="1">Treatment period</th>
    <th align="center" rowspan="1" colspan="1">Dosage</th>
    <th align="center" rowspan="1" colspan="1">Mechanisms</th>
    <th align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Total alkaloids</td>
    <td align="center" rowspan="1" colspan="1">Lewis lung carcinoma cell</td>
    <td align="center" rowspan="1" colspan="1">0–72 h</td>
    <td align="center" rowspan="1" colspan="1">30 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing apoptosis by promoting the S-phase cell cycle arrest</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B47" ref-type="bibr">47</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Total alkaloids</td>
    <td align="center" rowspan="1" colspan="1">Male C57BL/6J mice</td>
    <td align="center" rowspan="1" colspan="1">10 days</td>
    <td align="center" rowspan="1" colspan="1">10–40 mg/kg/day</td>
    <td align="center" rowspan="1" colspan="1">Inhibiting tumor angiogenesis by downregulating CD31; inducing apoptosis through activating caspase-3</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B47" ref-type="bibr">47</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Aqueous extract</td>
    <td align="center" rowspan="1" colspan="1">Non-small-cell lung cancer A549 cells</td>
    <td align="center" rowspan="1" colspan="1">48 h</td>
    <td align="center" rowspan="1" colspan="1">0–100 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing G2/M arrest; inhibiting the expression of Bcl-2 while increasing the expression of Bax, STAT1, and STAT4 protein</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B48" ref-type="bibr">48</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Aqueous extract</td>
    <td align="center" rowspan="1" colspan="1">Female SPF mice</td>
    <td align="center" rowspan="1" colspan="1">20 days</td>
    <td align="center" rowspan="1" colspan="1">0.2 mL/2.5 mg/mL/2 day</td>
    <td align="center" rowspan="1" colspan="1">Upregulating the expression of STAT1, STAT4, IFN
     <italic>γ</italic>, IL-12, caspase-3, and Bax while decreasing Bcl-2 levels
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B48" ref-type="bibr">48</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Chuanbeinone</td>
    <td align="center" rowspan="1" colspan="1">Lewis lung carcinoma cells</td>
    <td align="center" rowspan="1" colspan="1">48 h</td>
    <td align="center" rowspan="1" colspan="1">5–15 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing S-phase arrest; inhibiting the expression of the antiapoptotic Bcl-2 while increasing the expression of proapoptotic protein Bax and caspase-3</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B49" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Chuanbeinone</td>
    <td align="center" rowspan="1" colspan="1">Male C57BL/6J mice and ICR mice</td>
    <td align="center" rowspan="1" colspan="1">10 days</td>
    <td align="center" rowspan="1" colspan="1">10–40 mg/kg/day</td>
    <td align="center" rowspan="1" colspan="1">Inhibiting tumor angiogenesis via downregulating CD31; inducing apoptosis through activating caspase-3</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B49" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine</td>
    <td align="center" rowspan="1" colspan="1">Human lung adenocarcinoma cell line A549</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">200 ng/mL</td>
    <td align="center" rowspan="1" colspan="1">Downregulating the levels of PI3K Class III, Akt, p-Akt, NIK, IKK
     <italic>α</italic>&amp;
     <italic>β</italic>, I
     <italic>κ</italic>B
     <italic>α</italic>, and Ki67; upregulating the levels of caspase-3
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B50" ref-type="bibr">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (lung cancer)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine</td>
    <td align="center" rowspan="1" colspan="1">Male BALB/c nude mice</td>
    <td align="center" rowspan="1" colspan="1">18 days</td>
    <td align="center" rowspan="1" colspan="1">10 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Downregulating the levels of IL-1
     <italic>β</italic>, IL-6, TNF-
     <italic>α</italic>, and Ki67
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B50" ref-type="bibr">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (colorectal cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Colorectal carcinoma HCT-116 cells</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–400 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Elevating ratio of LC3B-II/LC3B-I; downregulating the expression of p-mTOR, p-Akt, p-PTEN; upregulating the expression of p-ULK1, p-AMPK, caspase-9, and cleaved caspase-3</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B51" ref-type="bibr">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (colorectal cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Female BALB/c nude mice</td>
    <td align="center" rowspan="1" colspan="1">14 days</td>
    <td align="center" rowspan="1" colspan="1">3 mg/kg/2 days</td>
    <td align="center" rowspan="1" colspan="1">Upregulating the expression of LC3B and cleaved caspase-3</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B51" ref-type="bibr">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (colorectal cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Colorectal carcinoma HCT-116 cells</td>
    <td align="center" rowspan="1" colspan="1">48 h</td>
    <td align="center" rowspan="1" colspan="1">0–400 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing cancer cell apoptosis and autophagy via modulating the production of metabolites (glucose, glutamine, oleate, and lignocerate)</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B52" ref-type="bibr">52</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (liver cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">HepG2 cells</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–6 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing G2/M phase cells arrest; increasing the expression of Bax, cleaved PARP, and caspase-3,8,9; decreasing the expression of Bcl-2 and Chk2</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B53" ref-type="bibr">53</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (endometrial cancer)</td>
    <td align="center" rowspan="1" colspan="1">Aqueous extract</td>
    <td align="center" rowspan="1" colspan="1">Human endometrial cancer cell lines Ishikawa and HEC-1B</td>
    <td align="center" rowspan="1" colspan="1">72 h</td>
    <td align="center" rowspan="1" colspan="1">200 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the expression of TGF-
     <italic>β</italic>, TGF-
     <italic>β</italic>R1, TGF-
     <italic>β</italic>R2, SMADS, 
     <italic>α</italic>v
     <italic>β</italic>3, MMP-2, MMP-9, FAK, snail, and slug
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B54" ref-type="bibr">54</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (endometrial cancer and ovarian cancer)</td>
    <td align="center" rowspan="1" colspan="1">Aqueous extract</td>
    <td align="center" rowspan="1" colspan="1">Human ovarian surface epithelial, HOSE 642, and ovarian cancer cell lines OVCA 420 and OVCA 429</td>
    <td align="center" rowspan="1" colspan="1">96 h</td>
    <td align="center" rowspan="1" colspan="1">200 mg/mL</td>
    <td align="center" rowspan="1" colspan="1">Inducing S-phase cell cycle arrest by decreasing expression of cyclin D1, D3; increasing expression of p27
     <break/>Inhibiting the expression of NF-
     <italic>κ</italic>Bp50, p-I
     <italic>κ</italic>Ba, CXCR4 and MMP-9; increasing the expression of caspase-3
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B55" ref-type="bibr">55</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (ovarian cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peimisine</td>
    <td align="center" rowspan="1" colspan="1">Human ovarian cancer cell line (A2780)</td>
    <td align="center" rowspan="1" colspan="1">0–72 h</td>
    <td align="center" rowspan="1" colspan="1">15 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inducing apoptosis by increasing G0/G1 phase cell arrest</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B56" ref-type="bibr">56</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-cancer (oral cancer)</td>
    <td align="center" rowspan="1" colspan="1">Peimine</td>
    <td align="center" rowspan="1" colspan="1">Normal human oral keratinocytes (NHOK) and gingival fibroblasts (GF)</td>
    <td align="center" rowspan="1" colspan="1">3 days</td>
    <td align="center" rowspan="1" colspan="1">50 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Downregulated the expression of Bcl-2 and pRb; upregulated the expression of Bax, caspase-3, p53, and p21</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B57" ref-type="bibr">57</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anticancer (myelogenous leukemia)</td>
    <td align="center" rowspan="1" colspan="1">Peimine</td>
    <td align="center" rowspan="1" colspan="1">Human Promyelocytic Leukemia HL-60 Cells</td>
    <td align="center" rowspan="1" colspan="1">4 days</td>
    <td align="center" rowspan="1" colspan="1">2.5, 5.0 mM</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B58" ref-type="bibr">58</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (cough)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, chuanbeinone, peimine, and peiminine</td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">1 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Enhancing the latent period of cough and inhibiting the cough frequency</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B59" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (cough)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, imperialine-
     <italic>β</italic>-N-oxide, isoverticine, and isoverticine-
     <italic>β</italic>-N-oxide
    </td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">1 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0, 4.5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Enhancing the latent period of cough and inhibiting the cough frequency</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B60" ref-type="bibr">60</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (cough)</td>
    <td align="center" rowspan="1" colspan="1">Crude alkaloid and water extracts</td>
    <td align="center" rowspan="1" colspan="1">The rat bronchi and tracheas</td>
    <td align="center" rowspan="1" colspan="1">10-9-10–5 g/mL
     <break/>10-7-10–3 g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">5–7 min</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B61" ref-type="bibr">61</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (expectorant)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, chuanbeinone, peimine, and peiminine</td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">0.5 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Enhancing tracheal phenol red output</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B59" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (expectorant)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, imperialine-
     <italic>β</italic>-N-oxide, isoverticine, and isoverticine-
     <italic>β</italic>-N-oxide
    </td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">0.5 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0, 4.5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Enhancing tracheal phenol red output</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B60" ref-type="bibr">60</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (acute lung injury)</td>
    <td align="center" rowspan="1" colspan="1">Total alkaloid</td>
    <td align="center" rowspan="1" colspan="1">C57BL/6J mice</td>
    <td align="center" rowspan="1" colspan="1">5 days</td>
    <td align="center" rowspan="1" colspan="1">15–60 mg/kg/day</td>
    <td align="center" rowspan="1" colspan="1">Decreasing the levels of TNF-
     <italic>α</italic> and IL-6
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B62" ref-type="bibr">62</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (acute lung injury)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Sprague Dawley (SD) rats</td>
    <td align="center" rowspan="1" colspan="1">28 days</td>
    <td align="center" rowspan="1" colspan="1">0.005 g/kg</td>
    <td align="center" rowspan="1" colspan="1">Decreasing the levels of IFN-
     <italic>γ</italic> in serum and TGF-
     <italic>β</italic>, CTGF, ERK1/2, NF-
     <italic>κ</italic>B, and FasL in lung tissue
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B63" ref-type="bibr">63</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (acute lung injury)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Male BALB/c mice</td>
    <td align="center" rowspan="1" colspan="1">6 h</td>
    <td align="center" rowspan="1" colspan="1">0–5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Inhibiting the expression of TNF-
     <italic>α</italic>, IL-1
     <italic>β</italic>, IL-6, IL-8, and AKT/PI3K; attenuating lipid rafts formation
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B64" ref-type="bibr">64</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (chronic obstructive pulmonary disease)</td>
    <td align="center" rowspan="1" colspan="1">Imperialine</td>
    <td align="center" rowspan="1" colspan="1">Wistar rats</td>
    <td align="center" rowspan="1" colspan="1">60 days</td>
    <td align="center" rowspan="1" colspan="1">3.5, 7.0 mg/kg/twice/day</td>
    <td align="center" rowspan="1" colspan="1">Decreasing the levels of IL-1
     <italic>β</italic>, IL-6, IL-8, TNF-
     <italic>α</italic>, NF-
     <italic>κ</italic>B p65, TGF-
     <italic>β</italic>1, MMP-9, and TIMP-1
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B65" ref-type="bibr">65</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (chronic obstructive pulmonary disease)</td>
    <td align="center" rowspan="1" colspan="1">Chuan Bei Pi Pa dropping pills</td>
    <td align="center" rowspan="1" colspan="1">Male Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">35 days</td>
    <td align="center" rowspan="1" colspan="1">50–200 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Decreasing the number of leukocytes</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B66" ref-type="bibr">66</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (chronic obstructive pulmonary disease)</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">HBSMC cells</td>
    <td align="center" rowspan="1" colspan="1">0-1 h</td>
    <td align="center" rowspan="1" colspan="1">10 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the expression of p-AKT and p-GSK3
     <italic>β</italic>; increasing the expression of p-MLC2
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B66" ref-type="bibr">66</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antirespiratory disease (asthma)</td>
    <td align="center" rowspan="1" colspan="1">Aqueous extract</td>
    <td align="center" rowspan="1" colspan="1">Male C57BL/6 mice</td>
    <td align="center" rowspan="1" colspan="1">56 days</td>
    <td align="center" rowspan="1" colspan="1">200 mg/kg/three times/week</td>
    <td align="center" rowspan="1" colspan="1">Suppressing Th2 cytokines (IL-4, IL-5, and IL-13), IgE, and histamine production; reducing eosinophilic accumulation; and increasing of interferon-
     <italic>γ</italic> production
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B67" ref-type="bibr">67</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Total alkaloids</td>
    <td align="center" rowspan="1" colspan="1">SD rats</td>
    <td align="center" rowspan="1" colspan="1">7 days</td>
    <td align="center" rowspan="1" colspan="1">0–14 mg/kg/day</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B62" ref-type="bibr">62</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, chuanbeinone, peimine, and peiminine</td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">0.5 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B59" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, imperialine-
     <italic>β</italic>-N-oxide, isoverticine, and isoverticine-
     <italic>β</italic>-N-oxide
    </td>
    <td align="center" rowspan="1" colspan="1">Kunming mice</td>
    <td align="center" rowspan="1" colspan="1">0.5 h</td>
    <td align="center" rowspan="1" colspan="1">1.5, 3.0, 4.5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B60" ref-type="bibr">60</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Peimine</td>
    <td align="center" rowspan="1" colspan="1">RAW264.7 macrophages</td>
    <td align="center" rowspan="1" colspan="1">18 h</td>
    <td align="center" rowspan="1" colspan="1">0–25 mg/L</td>
    <td align="center" rowspan="1" colspan="1">Inhibiting the expression of TNF-
     <italic>α</italic>, IL-6, IL-1
     <italic>β</italic>, p38, ERK, JNK, p65, and IkB; increasing the expression of IL-10
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B68" ref-type="bibr">68</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Imperialine and peimine</td>
    <td align="center" rowspan="1" colspan="1">RAW264.7 macrophages</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–150 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the expression of NO, iNOS, COX-2, TNF-
     <italic>α</italic>, IL-1
     <italic>β</italic>, and P-NF-
     <italic>κ</italic>B p65
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B69" ref-type="bibr">69</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Anti-inflammation</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, peiminine, delavine, peimisine, and peimine</td>
    <td align="center" rowspan="1" colspan="1">RAW264.7 macrophages</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–40 
     <italic>μ</italic>M
     <break/>0–10 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the expression of NO, TNF-
     <italic>α</italic>, IL-1
     <italic>β</italic>, IL-6, ERK1/2, p38 MAPK, and JNK/SAPK
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B70" ref-type="bibr">70</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Antioxidation</td>
    <td align="center" rowspan="1" colspan="1">Imperialine, peimine, peiminine, peimisine, imperialine-3-
     <italic>β</italic>-D-glucoside, and delavine
    </td>
    <td align="center" rowspan="1" colspan="1">RAW264.7 macrophages</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–50 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the levels of ROS; increasing the levels of glutathione, HO-1, and Nrf2</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B71" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Parkinson's disease</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Female Wistar rats</td>
    <td align="center" rowspan="1" colspan="1">28 days</td>
    <td align="center" rowspan="1" colspan="1">0–5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">—</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B72" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Parkinson's disease</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">BV-2 cells</td>
    <td align="center" rowspan="1" colspan="1">13 h</td>
    <td align="center" rowspan="1" colspan="1">0–50 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Decreasing the expression of TNF-
     <italic>α</italic>, IL-6, IL-1
     <italic>β</italic>, COX-2, iNOS, ERK1/2, AKT, and NF-
     <italic>κ</italic>B p65
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B72" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Mastitis</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">BALB/c mice</td>
    <td align="center" rowspan="1" colspan="1">13 h</td>
    <td align="center" rowspan="1" colspan="1">0–5 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Inhibiting the expression of myeloperoxidase, TNF-
     <italic>α</italic>, IL-6, IL-1
     <italic>β</italic>, COX-2, iNOS, AKT, NF-
     <italic>κ</italic>Bp65, ERK1/2, and p38
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B73" ref-type="bibr">73</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Mastitis</td>
    <td align="center" rowspan="1" colspan="1">Peiminine</td>
    <td align="center" rowspan="1" colspan="1">Mouse mammary epithelial cells (mMECs)</td>
    <td align="center" rowspan="1" colspan="1">4 h</td>
    <td align="center" rowspan="1" colspan="1">0–70 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibiting the expression of TNF-
     <italic>α</italic>, IL-6, IL-1
     <italic>β</italic>, COX-2, iNOS, AKT, NF-
     <italic>κ</italic>Bp65, ERK1/2, and p38
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B73" ref-type="bibr">73</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Diabetes</td>
    <td align="center" rowspan="1" colspan="1">Peimine</td>
    <td align="center" rowspan="1" colspan="1">b-TC6 pancreatic and C2C12 skeletal muscle cells</td>
    <td align="center" rowspan="1" colspan="1">24 h</td>
    <td align="center" rowspan="1" colspan="1">0–100 
     <italic>μ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">Increasing the levels of insulin secreted into the media and glucose uptake ability</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B74" ref-type="bibr">74</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
